Page last updated: 2024-09-04

moxifloxacin and Helicobacter Infections

moxifloxacin has been researched along with Helicobacter Infections in 58 studies

Research

Studies (58)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	13 (22.41)	29.6817
2010's	42 (72.41)	24.3611
2020's	3 (5.17)	2.80

Authors

Authors	Studies
Areia, M; Barrio, J; Beglinger, C; Bordin, D; Boyanova, L; Bujanda, L; Buzas, GM; Bytzer, P; Caldas, M; Capelle, L; Castro-Fernandez, M; Doulberis, M; Fernandez-Salazar, L; Gasbarrini, A; Gisbert, JP; Goldis, A; Huguet, JM; Jonaitis, L; Jurecic, NB; Kunovský, L; Kupčinskas, J; Lamy, V; Lanas, A; Lasala, JP; Leja, M; Lerang, F; Lucendo, AJ; Marcos-Pinto, R; Marlicz, W; Megraud, F; Milivojevic, V; Molina-Infante, J; Morain, CO; Niv, Y; Nyssen, OP; Ortuño, J; Pérez Aísa, Á; Phull, P; Puig, I; Rodrigo, L; Rokkas, T; Sarsenbaeva, AS; Shvets, O; Simsek, I; Smith, S; Tepes, B; Tonkić, A; Vaira, D; Venerito, M; Vologzhanina, L; Voynovan, I	1
Choi, SI; Jang, JY; Kim, N; Lee, DH; Lee, JW; Nam, RH; Song, CH	1
Chu, N; Gu, Y; Luo, H; Wang, Q; Xiao, Y; Yang, J; Zhang, J	1
Gisbert, JP; Marin, AC; McNicholl, AG; Nyssen, OP	1
Fattahi, G; Safarnejad, S; Shafahi Tilaki, S; Talebi Bezmin Abadi, A	1
Choi, YJ; Kang, JB; Kim, N; Kwon, S; Lee, DH; Park, YS; Shin, CM; Yoon, H	2
Morgando, A; Younes, R	1
Heo, JJ; Jung, K; Kim, JH; Kim, SE; Moon, W; Park, MI; Park, SJ; Roh, JH	1
Kılıç, ZMY; Özer Etik, D; Öztaş, E; Sezer, S; Suna, N	1
Bao, Z; Dong, F; Huang, Y; Liu, F; Yin, S; Zhang, G; Zou, J	1
Jo, HJ; Kim, MS; Kim, N; Kim, SE; Lee, DH; Park, YS; Shin, CM	1
Ang, TL; Song, M	1
Jung, HC; Kang, KK; Kim, N; Lee, DH; Oh, DH; Park, YS; Shin, CM; Yoon, H	1
Choi, YJ; Jung, HC; Kim, JM; Kim, JS; Kim, N; Lee, JW; Nam, RH; Park, JH	1
Akdoğan, RA; Bedir, R; Copur, A; Rakici, H; Yilmaz, A	1
Jo, HJ; Kim, N; Lee, DH; Lee, ST; Lim, JH; Park, YS; Shin, CM; Song, IS	1
Cho, Y; Chung, KH; Hwang, JH; Jeong, SH; Jin, E; Kim, JW; Kim, N; Lee, DH; Seo, JY; Shin, CM	1
Almela, P; Angueira, T; Ariño, I; Barrio, J; Bermejo, F; Domínguez, JL; Domínguez-Muñoz, JE; Federico, A; Fernández, N; Fernandez-Bermejo, M; Ferrer-Barcelo, L; Gisbert, JP; Gomez, B; Gomez-Camarero, J; Gravina, AG; Lucendo, AJ; Marín, AC; Martin-Noguerol, E; Martorano, M; McNicholl, AG; Medina, E; Millastre, J; Miranda, A; Modolell, I; Molina-Infante, J; Ortuño, J; Perez-Aisa, Á; Perona, M; Rodríguez-Tellez, M; Romano, M	1
Akdogan, RA; Ayaz, T; Bedir, R; Rakici, H	1
Hwang, JJ; Kim, N; Lee, AR; Lee, DH; Park, YS; Shin, CM; Yoon, H	2
Bai, P; Ding, Y; Luo, Y; Xiao, XM; Zhou, LY	1
Hwang, JJ; Kim, N; Lee, DH; Park, YS; Shin, CM; Yoon, H	1
Jung, HC; Kim, JM; Kim, JS; Kim, N; Lee, DH; Lee, JW; Lee, SM; Nam, RH; Park, JY	1
Krogfelt, KA; Nielsen, HL; Prag, J	1
Choi, YJ; Kim, N; Kwon, YH; Lee, DH; Lee, JW; Lee, JY; Nam, RH; Suh, JH; Yoon, K	1
Cataldi, V; Cellini, L; Ciccaglione, AF; Di Bartolomeo, S; Di Campli, E; Di Giulio, M; Grossi, L; Marzio, L; Nostro, A	1
Kim, N; Lee, DH; Lee, ST; Lim, JH; Park, YS; Shin, CM; Song, IS	1
Bago, J; Dominković, L; Gulić, S; Majstorović Barać, K; Marušić, M; Pezerović, D	1
Bago, J; Bago, P; Bakula, V; Marusić, M; Pevec, B; Tomić, M	1
Hwang, TJ; Jung, HC; Kim, N; Lee, BH; Lee, DH; Nam, RH; Park, YS; Song, IS; Yoon, H	1
Amitrano, M; Grossi, L; Manzoli, L; Marzio, L; Sacco, F; Spezzaferro, M	1
Bin, M; Donghai, W; Kehu, Y; Lijuan, Y; Quanlin, G; Wenzhen, Y; Yumin, L	1
Xu, L; Zheng, XL	1
Chen, YL; Li, WQ; Lu, D; Wang, CD; Wu, T; Zhuang, ZH	1
Bago, J; Bago, P; Bakula, V; Belosić-Halle, Z; Kućisec, N; Majstorović, K; Tomić, M; Troskot, R	1
Huang, X; Li, Y; Shi, R; Yao, L; Zhang, G	1
Hsueh, PR; Lee, PI; Yang, JC	1
Jung, HC; Kim, JY; Kim, N; Park, JH; Park, SY; Song, IS; Yoon, H	1
Akbal, E; Koçak, E; Köklü, S; Taş, A	1
Chen, X; Li, MY; Liu, J; Wang, ZQ; Wu, C; Zhang, ZQ	1
Ghasemzadeh, A; Mobarez, AM; Taghvaei, T; Talebi Bezmin Abadi, A	1
Baik, GH; Jung, HC; Kim, GH; Kim, HB; Kim, JM; Kim, JY; Kim, NY; Kim, SJ; Lee, DH; Nam, RH; Song, IS	1
Berning, M; Krasz, S; Labenz, J; Miehlke, S; Morgner, A	1
Berning, M; Jebens, C; Knoth, H; Krasz, S; Kuhlisch, E; Laass, MW; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Neumeyer, M; Schneider-Brachert, W; Stolte, M; Vieth, M; Zekorn, C	1
Cellini, L; Ciccaglione, AF; Grossi, L; Marzio, L	1
Ergül, B; Filik, L; Koçak, E; Köklü, S; Taş, A	1
Cheon, JH; Hwang, JH; Jung, HC; Kim, JM; Kim, JW; Kim, N; Lee, DH; Park, YS; Song, IS; Suh, SO	1
Cammarota, G; Candelli, M; Cazzato, IA; Cremonini, F; Finizio, R; Gasbarrini, A; Gasbarrini, G; Nista, EC; Ojetti, V; Pignataro, G; Santoro, M; Zocco, MA	1
Jung, HC; Kim, JM; Kim, JS; Kim, N; Song, IS	1
Cheon, JH; Jung, HC; Kim, JM; Kim, JS; Kim, N; Lee, DH; Song, IS	1
Bago, J; Bago, P; Marusić, M; Rozankovic, M; Tomic, M; Vcev, A	1
Altintaş, E; Sezgin, O; Tellioğlu, B; Tombak, A; Uçbilek, E	1
Jung, HC; Kang, JM; Kim, JS; Kim, N; Kim, YR; Lee, DH; Park, YS; Song, IS	1
Bästlein, E; Haferland, C; Jebens, C; Kirsch, C; Knoth, H; Kuhlisch, E; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Schneider-Brachert, W; Stolte, M; Zekorn, C	1
Cakal, B; Kiliç, ZM; Köksal, AS; Kuran, S; Nadir, I; Ozin, YO; Sahin, B	1
Bartolozzi, F; Cammarota, G; Candelli, M; Cremonini, F; Di Caro, S; Gasbarrini, A; Lupascu, A; Nista, EC; Ojetti, V; Zocco, MA	1

Reviews

7 review(s) available for moxifloxacin and Helicobacter Infections

Article	Year
Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis. Drugs, 2017, Volume: 77, Issue:7 Topics: Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Proton Pump Inhibitors; Quinolones	2017
The efficacy of moxifloxacin-based triple therapy in treatment of Helicobacter pylori infection: a systematic review and meta-analysis of randomized clinical trials. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2013, Volume: 46, Issue:7 Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Moxifloxacin; Randomized Controlled Trials as Topic	2013
Second and third line treatment options for Helicobacter pylori eradication. World journal of gastroenterology, 2014, Feb-14, Volume: 20, Issue:6 Topics: Anti-Bacterial Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Moxifloxacin; Ofloxacin; Rifabutin; Rifamycins; Rifaximin; Salvage Therapy; Virulence Factors	2014
Moxifloxacin-based triple therapy versus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection: a meta-analysis of randomized controlled trials. Internal medicine (Tokyo, Japan), 2009, Volume: 48, Issue:24 Topics: Aza Compounds; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Moxifloxacin; Odds Ratio; Proton Pump Inhibitors; Quinolines; Randomized Controlled Trials as Topic; Treatment Outcome	2009
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis. Wiener klinische Wochenschrift, 2010, Volume: 122, Issue:13-14 Topics: Anti-Infective Agents; Aza Compounds; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Proton Pump Inhibitors; Quinolines; Randomized Controlled Trials as Topic; Recurrence; Retreatment	2010
Moxifloxacin-containing triple therapy versus bismuth-containing quadruple therapy for second-line treatment of Helicobacter pylori infection: a meta-analysis. Helicobacter, 2011, Volume: 16, Issue:2 Topics: Aza Compounds; Bismuth; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Humans; Moxifloxacin; Quinolines; Treatment Outcome	2011
[Current value of quinolones in Helicobacter pylori therapy]. Zeitschrift fur Gastroenterologie, 2011, Volume: 49, Issue:8 Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines	2011

Trials

26 trial(s) available for moxifloxacin and Helicobacter Infections

Article	Year
Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea. Helicobacter, 2023, Volume: 28, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Prevalence; Republic of Korea; Tertiary Care Centers	2023
Can the treatment duration be shortened in bismuth-containing therapies for Helicobacter pylori eradication? The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2019, Volume: 30, Issue:8 Topics: Adult; Antacids; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duration of Therapy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Treatment Outcome	2019
Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy. BMC gastroenterology, 2013, Sep-19, Volume: 13 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Disease-Free Survival; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Peptic Ulcer; Quinolines; Recurrence; Stomach Neoplasms; Tetracycline; Treatment Outcome	2013
Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates. Journal of digestive diseases, 2014, Volume: 15, Issue:9 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Treatment Outcome; Young Adult	2014
Comparison of levofloxacin- and moxifloxacin-based triple therapies with standard treatment in eradication of Helicobacter pylori as first-line therapy. Digestion, 2014, Volume: 90, Issue:4 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Treatment Outcome; Young Adult	2014
Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease. World journal of gastroenterology, 2015, Apr-28, Volume: 21, Issue:16 Topics: Aged; Anti-Bacterial Agents; Biopsy; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Metronidazole; Middle Aged; Moxifloxacin; Multivariate Analysis; Odds Ratio; Pilot Projects; Predictive Value of Tests; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Stomach Diseases; Time Factors; Treatment Outcome	2015
Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication. World journal of gastroenterology, 2015, Sep-21, Volume: 21, Issue:35 Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Metronidazole; Middle Aged; Moxifloxacin; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Time Factors; Treatment Outcome	2015
Comparison of the efficacy of culture-based tailored therapy for Helicobacter pylori eradication with that of the traditional second-line rescue therapy in Korean patients: a prospective single tertiary center study. Scandinavian journal of gastroenterology, 2016, Volume: 51, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Republic of Korea; Tertiary Care Centers; Tetracycline; Young Adult	2016
Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial. Wiener klinische Wochenschrift, 2009, Volume: 121, Issue:1-2 Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Quinolines; Recurrence; Retreatment; Single-Blind Method; Tetracycline; Young Adult	2009
Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:2 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Urea; Young Adult	2010
[Efficacy of second-line treatment based on moxifloxacin triple therapy for Helicobacter pylori infection]. Zhonghua yi xue za zhi, 2010, Jan-12, Volume: 90, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Treatment Failure; Young Adult	2010
Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial. Annals of clinical microbiology and antimicrobials, 2010, Apr-15, Volume: 9 Topics: Adult; Anti-Infective Agents; Aza Compounds; Drug Administration Schedule; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Time Factors; Treatment Outcome	2010
Effects of multistrain probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori infection. Journal of gastroenterology and hepatology, 2011, Volume: 26, Issue:1 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Bifidobacterium; Breath Tests; Chi-Square Distribution; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Lacticaseibacillus casei; Lactobacillus acidophilus; Male; Middle Aged; Moxifloxacin; Probiotics; Prospective Studies; Proton Pump Inhibitors; Quinolines; Republic of Korea; Streptococcus thermophilus; Time Factors; Treatment Outcome; Urease; Yogurt	2011
Moxifloxacin-tetracycline-lansoprazole triple therapy for first-line treatment of Helicobacter pylori infection: a prospective study. Helicobacter, 2011, Volume: 16, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Tetracycline; Treatment Outcome; Young Adult	2011
Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection. Helicobacter, 2011, Volume: 16, Issue:6 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Quinolines; Salvage Therapy; Time Factors; Treatment Outcome; Urea; White People	2011
Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori. World journal of gastroenterology, 2012, Aug-28, Volume: 18, Issue:32 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Organometallic Compounds; Pantoprazole; Proton Pump Inhibitors; Quinolines; Treatment Outcome	2012
Bismuth, moxifloxacin, tetracycline, lansoprazole quadruple first line therapy for eradication of H. pylori: A prospective study. Clinics and research in hepatology and gastroenterology, 2013, Volume: 37, Issue:5 Topics: Adult; Aged; Antacids; Anti-Bacterial Agents; Aza Compounds; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Middle Aged; Moxifloxacin; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Quinolines; Tetracycline; Young Adult	2013
[Trial of moxifloxacin-containing triple therapy after initial and second-line treatment failures for Helicobacter pylori infection]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2005, Volume: 45, Issue:2 Topics: Adult; Aged; Antacids; Anti-Bacterial Agents; Aza Compounds; Bismuth; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Quinolines	2005
Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 2005, May-15, Volume: 21, Issue:10 Topics: Adult; Amoxicillin; Aza Compounds; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Patient Compliance; Prospective Studies; Quinolines; Tinidazole; Treatment Outcome	2005
Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection. Helicobacter, 2006, Volume: 11, Issue:1 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Patient Compliance; Quinolines; Tetracycline; Treatment Outcome	2006
High eradication rate of H. pylori with moxifloxacin-based treatment: a randomized controlled trial. Wiener klinische Wochenschrift, 2007, Volume: 119, Issue:11-12 Topics: Anti-Infective Agents; Aza Compounds; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Treatment Outcome	2007
Low efficacy rate of moxifloxacin-containing Helicobacter pylori eradication treatment: in an observational study in a Turkish population. Helicobacter, 2007, Volume: 12, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Aza Compounds; Drug Therapy, Combination; Dyspepsia; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Pantoprazole; Peptic Ulcer; Pilot Projects; Quinolines; Treatment Outcome; Turkey	2007
Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy. Helicobacter, 2007, Volume: 12, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Patient Compliance; Quinolines; Tetracycline	2007
One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin. Helicobacter, 2008, Volume: 13, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Aza Compounds; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Mixed Function Oxygenases; Moxifloxacin; Polymorphism, Restriction Fragment Length; Prospective Studies; Quinolines; Rifabutin	2008
Moxifloxacine plus amoxicillin and ranitidine bismuth citrate or esomeprazole triple therapies for Helicobacter pylori infection. Digestive diseases and sciences, 2008, Volume: 53, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Aza Compounds; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Humans; Male; Middle Aged; Moxifloxacin; Pilot Projects; Prospective Studies; Quinolines; Ranitidine; Treatment Outcome; Young Adult	2008
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Combinations; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Moxifloxacin; Omeprazole; Patient Compliance; Quinolines; Treatment Outcome	2002

Other Studies

25 other study(ies) available for moxifloxacin and Helicobacter Infections

Article	Year
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg). Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2022, Volume: 20, Issue:10 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Penicillins; Prospective Studies; Proton Pump Inhibitors; Quinolones; Registries; Tetracycline	2022
Antimicrobial Resistance of Helicobacter Pylori Among Low-resource Chinese Minorities. Alternative therapies in health and medicine, 2023, Volume: 29, Issue:2 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; China; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; East Asian People; Female; Gentamicins; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Moxifloxacin; Rifampin	2023
Moxifloxacin, but not Metronidazole can be used in therapeutic regimens against Helicobacter pylori. Minerva gastroenterologica e dietologica, 2017, Volume: 63, Issue:2 Topics: Amoxicillin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Moxifloxacin	2017
[The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure in The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2017, Aug-25, Volume: 70, Issue:2 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Topoisomerase II Inhibitors; Treatment Failure; Treatment Outcome	2017
Comment on Helicobacter pylori eradication using metronidazole. Minerva gastroenterologica e dietologica, 2018, Volume: 64, Issue:1 Topics: Amoxicillin; Bismuth; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Moxifloxacin	2018
[The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure in Helicobacter pylori Eradication]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2018, 04-25, Volume: 71, Issue:4 Topics: Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Nausea; Patient Compliance; Proton Pump Inhibitors; Retrospective Studies; Treatment Failure; Treatment Outcome	2018
Effect of 7-day Bismuth Quadruple Therapy versus 14-day Moxifloxacin Triple Therapy for Second-line The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2019, Jan-25, Volume: 73, Issue:1 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome	2019
Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea. World journal of gastroenterology, 2014, Jun-14, Volume: 20, Issue:22 Topics: Adult; Aged; Anti-Bacterial Agents; Breath Tests; Chi-Square Distribution; Drug Substitution; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Republic of Korea; Retrospective Studies; Salvage Therapy; Time Factors; Treatment Failure	2014
GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea. Scandinavian journal of gastroenterology, 2014, Volume: 49, Issue:9 Topics: Aged; Anti-Bacterial Agents; Clarithromycin; DNA Gyrase; DNA Mutational Analysis; Drug Combinations; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genotyping Techniques; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Point Mutation; Republic of Korea; RNA, Ribosomal, 23S; Sensitivity and Specificity	2014
Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection. Gut and liver, 2015, Volume: 9, Issue:4 Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Retrospective Studies; Tetracycline; Treatment Outcome	2015
The efficacy of moxifloxacin-containing triple therapy after standard triple, sequential, or concomitant therapy failure for Helicobacter pylori eradication in Korea. Gut and liver, 2014, Volume: 8, Issue:6 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Cohort Studies; Drug Therapy, Combination; Female; Fluoroquinolones; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Peptic Ulcer; Rabeprazole; Republic of Korea; Retrospective Studies; Salvage Therapy; Stomach; Tetracycline; Treatment Failure; Treatment Outcome; Urea	2014
Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2015, Volume: 47, Issue:2 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Cohort Studies; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Proton Pump Inhibitors; Retreatment; Treatment Failure; Treatment Outcome; Urea	2015
Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication. World journal of gastroenterology, 2015, May-14, Volume: 21, Issue:18 Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult	2015
Susceptibility of Helicobacter pylori to antibiotics in Chinese patients. Journal of digestive diseases, 2015, Volume: 16, Issue:8 Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Minocycline; Moxifloxacin; Peptic Ulcer; Risk Factors; Young Adult	2015
High Efficacy of Finafloxacin on Helicobacter pylori Isolates at pH 5.0 Compared with That of Other Fluoroquinolones. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12 Topics: Amino Acid Substitution; Anti-Bacterial Agents; Asparagine; Aspartic Acid; DNA Gyrase; Female; Fluoroquinolones; Gene Expression; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Point Mutation; Treatment Outcome	2015
Helicobacter cinaedi knee infection after arthroscopy in an immunocompetent patient. BMJ case reports, 2015, Oct-06, Volume: 2015 Topics: Adult; Anti-Bacterial Agents; Arthroscopy; Fever; Fluoroquinolones; Helicobacter; Helicobacter Infections; Humans; Knee Injuries; Knee Joint; Male; Moxifloxacin; Rifampin; Species Specificity; Synovial Fluid; Treatment Outcome	2015
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy. Scandinavian journal of gastroenterology, 2016, Volume: 51, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Child; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Fluoroquinolones; Gastric Fundus; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pyloric Antrum; Rifabutin; Tetracycline; Young Adult	2016
Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection. World journal of gastroenterology, 2015, Dec-14, Volume: 21, Issue:46 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Breath Tests; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Rabeprazole; Retreatment; Retrospective Studies; Time Factors; Treatment Failure	2015
Bismuth-based quadruple therapy modified with moxifloxacin for Helicobacter pylori eradication. Minerva gastroenterologica e dietologica, 2017, Volume: 63, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Drug Therapy, Combination; Female; Fluoroquinolones; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Pantoprazole; Patient Compliance; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome	2017
Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate. Helicobacter, 2009, Volume: 14, Issue:5 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Drug Resistance, Microbial; Drug Therapy, Combination; Esomeprazole; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Treatment Outcome	2009
[Efficacy of moxifloxacin-based triple therapy to eradicate Helicobacter pylori infection]. Zhonghua yi xue za zhi, 2010, Jan-12, Volume: 90, Issue:2 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines	2010
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:11 Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline	2010
Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran. Internal and emergency medicine, 2012, Volume: 7, Issue:5 Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Young Adult	2012
[Regional difference of antibiotic resistance of helicobacter pylori strains in Korea]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2011, Volume: 57, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Republic of Korea; Tetracycline	2011
Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:5 Topics: Amino Acid Substitution; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Point Mutation; Quinolines; Sequence Analysis, DNA	2005